Abstract Domestic dog breeds have undergone intense selection for a variety of morphologic features, including size. Among small-dog breeds, defined as those averaging less than *15 in. at the withers, there remains still considerable variation in body size. Yet essentially all such dogs are fixed for the same allele at the insulin-like growth factor 1 gene, which we and others previously found to be a size locus of large effect. In this study we sought to identify additional genes that contribute to tiny size in dogs using an association scan with the single nucleotide polymorphism (SNP) dataset CanMap, in which 915 purebred dogs were genotyped at 60,968 SNP markers. Our strongest association for tiny size (defined as breed-average height not more than 10 in. at the withers) was on canine chromosome 3 (p = 1.9 9 10 -70 ). Fine mapping revealed a nonsynonymous SNP at chr3:44,706,389 that changes a highly conserved arginine at amino acid 204 to histidine in the insulin-like growth factor 1 receptor (IGF1R). This mutation is predicted to prevent formation of several hydrogen bonds within the cysteine-rich domain of the receptor's ligand-binding extracellular subunit. Nine of 13 tiny dog breeds carry the mutation and many dogs are homozygous for it. This work underscores the central importance of the IGF1 pathway in controlling the tremendous size diversity of dogs.
Introduction
Body size is a prototypical complex trait (Lettre 2011). Although size is easy to measure and is highly heritable, it has proved a challenging trait to study in humans (Aulchenko et al. 2009; Perola 2011) . It is only relatively recently that large-scale genome-wide association scans (GWAS) have begun to identify loci associated with human height variation (Sanna et al. 2008; Weedon et al. 2007 ). Now, using dense SNP scans in large samples, 180 size-controlling loci have been identified in the human genome, but cumulatively they explain just *12 % of the heritable variation in height and the effect size of each variant is very small (Hirschhorn and Gajdos 2011; Kim et al. 2010; Lango Allen et al. 2010; Liu et al. 2010; Okada et al. 2010; Soranzo et al. 2009; Weedon et al. 2008) . Thus, the genetic control of human height is highly complex and studies to identify the genes involved require tremendous sample sizes to achieve sufficient statistical power.
Domestic dogs offer an important opportunity in this context: breeds are selected for specific body sizes and as a result purebred dogs vary fourfold in bone length measures (Sutter et al. 2008) . The majority of purebred dog size variation is between breeds rather than within them, consistent with the intense selection for size applied by breeders. In stark contrast to the complexity of size genetics in humans, Chase et al. (2002) showed that a single locus on canine chromosome 15 was strongly associated with size and could explain 10 % of the variation in size in the Portuguese Water Dog breed, a result subsequently verified (Jones et al. 2008; Sutter et al. 2007; Vaysse et al. 2011) . At this locus we found a single haplotype spanning the insulin-like growth factor 1 (IGF1) gene that had experienced a selective sweep to very high frequency in nearly all small breeds of dog (Sutter et al. 2007 ). Since the small-size-associated haplotype is widely shared among small breeds, developed for a variety of different reasons, the initial variant likely arose early in domestication. This haplotype appears to have originated in or near the Fertile Crescent (Gray et al. 2010) , which may also be one of the sites of dog domestication (vonHoldt et al. 2010) . Thus, via intense selection within inbred lines, an old haplotype rose to high frequency and today it has a very large effect on purebred dog size. This illustrates how the world's *400 dog breeds provide, in aggregate, a powerful tool for genetically dissecting complex traits . The power to map complex traits using dog breeds is especially high when the traits are under positive selection, as typified by size (Sutter et al. 2007 ), ear erectness (Vaysse et al. 2011) , snout length and body mass (Boyko et al. 2010) , brachycephaly , limb dwarfism (Parker et al. 2009 ), white spotting and hair ridge (Karlsson et al. 2007; Salmon Hillbertz et al. 2007) , pelage (Cadieu et al. 2009 ), and skin wrinkling (Olsson et al. 2011) .
Serum levels of IGF1 are correlated with both Poodle size (Eigenmann et al. 1984 ) and the selectively swept IGF1 haplotype (Sutter et al. 2007 ), but IGF1 is clearly not the only genetic variant controlling size. Jones et al. (2008) genotyped dogs from 148 breeds and identified the IGF1 locus as well as other loci significantly associated with breed-average height and weight traits, including five loci with strong candidate genes. Boyko et al. (2010) generated the CanMap dataset of 915 dogs from 80 breeds that were each genotyped at 60,968 SNPs and with these data identified numerous loci significantly associated with breed-average log(body weight) and morphometric measurements. A similar approach was recently used to study breed-average traits shared among 46 breeds using the Canine HD array of 172,000 SNPs (Vaysse et al. 2011) .
Nearly all small breeds of dog are fixed for the IGF1 haplotype, yet within this group of breeds there is still considerable size variation. With the aim of identifying genes contributing to the tiniest dog sizes (i.e., dogs in breeds averaging no more than 10 in. at the withers), we utilized the CanMap genotypes to conduct a GWAS for tiny size. Following fine-mapping, we identified a nonsynonymous SNP in the IGF1 receptor (IGF1R) that is associated with dog size.
Materials and methods

Sample collection and DNA isolation
Purebred dog data and biomaterials were collected under approved animal care and use committee protocols at Cornell University and NHGRI/NIH. Blood samples were collected into EDTA anticoagulant at dog shows or by soliciting owners. Genomic DNA (gDNA) was extracted from white blood cells using standard proteinase K/phenol:chloroform isolation (Sambrook and Russell 2001) . Pedigrees from samples used in the study were inspected to avoid including close relatives (usually meaning no dogs within any breed shared parents or grandparents with any other dog in that breed).
Phenotype assignment
Every dog within a given breed was assigned the same phenotypic value that represented an estimate of the typical size of dogs within that breed. For each breed we utilized web resources such as the published breed standards available at the American Kennel Club (AKC 1998) to estimate the average withers height for an adult male in the breed. This single value was then applied to all of our samples from that breed to represent that breed's size.
SNP genotyping
We utilized the CanMap Affymetrix genotyping dataset collected by Boyko et al. (2010) and described in detail in their paper and elsewhere (Cadieu et al. 2009 ). We also genotyped SNPs using two other approaches: (1) we identified SNPs from capillary sequence traces collected for mutation scanning, and (2) by fine-mapping using the SNPlex custom genotyping platform (Applied Biosystems, Carlsbad, CA).
Capillary sequencing
To generate amplicons for capillary sequencing (list of primers in Supplementary Table 1) , PCR primers were designed with Primer3 (Rozen and Skaletsky 2000) . Between 1 and 15 ng of gDNA (usually 10 ng) was used as template in a 10-ll PCR with AmpliTaq Gold DNA polymerase in the manufacturer's provided buffer (Applied Biosystems). PCR ran for 20 touchdown cycles (annealing temperature varying from 61°C to 51°C, dropping 0.5°C each cycle) followed by 20 more cycles at 51°C annealing temperature. Primers were removed from PCR amplicons using exonuclease I and shrimp alkaline phosphatase treatment at 37°C for 30 min, followed by incubation for 15 min at 80°C. Each PCR amplicon was sequenced in both directions using the PCR primer oligonucleotides to prime the sequencing reactions or, for a few amplicons, with internal sequencing primers. Sequencing reactions used the BigDye 3.1 Applied Biosystems master mix in a 5-ll reaction with 2 ll of the exo/SAP-cleaned PCR amplicon. Products from sequencing reactions were isolated by ethanol precipitation, suspended in 15 ll of water, and analyzed on an ABI3730 capillary sequencer.
SNPlex genotyping
Fine-mapping at the canine chromosome 3 locus utilized the SNPlex genotyping system from Applied Biosystems. Six pools of up to 48 SNPs each were designed to query a total of 287 SNPs. Genomic DNA samples (100-250 ng for each pool assay) were subjected to the SNPlex genotyping protocol, and raw genotype traces were collected on an ABI3730 following established procedures. SNP genotypes were called using GeneMapper (Applied Biosystems), and of the 287 attempted SNPs, 211 passed quality control and were found to be segregating two alleles in the sample population. These were included in the analyses.
Genetic analyses
PLINK (Purcell et al. 2007 ) and Haploview (Barrett et al. 2005) were used to test for significance of association and assess patterns of linkage disequilibrium (LD), respectively. PHASE (Stephens et al. 2001 ) was used to infer haplotypes spanning region 2 of the IGF1R gene. Using the phase_pairs output, we summed over the PHASE-assigned probability for each haplotype pair in each sample to accumulate the estimated chromosome counts for each haplotype for each breed.
IGF1R structure analysis and alignment
Crystallographic coordinates for domains 1-3 of the IGF1 receptor (Garrett et al. 1998) were downloaded from the RCSB protein databank (accession ID: 1IGR) and visualized using the PyMol Molecular Graphics System ver. 1.3 (Schroedinger, LLC). For the IGF1R and insulin receptor alignment, residues 192-213 of the predicted amino acid sequence for the dog IGF1R were used as a query in protein BLAST to search GenBank for sequences for the IGF1R and the insulin receptor from multiple species.
Results
We aimed to identify genetic factors that contribute to the body size phenotype of the tiniest dogs, defined as those with breed-average height B10 in. (25.4 cm) at the withers according to American Kennel Club resources (AKC 1998) . To do this, we made use of the genotypes from a previously published GWAS, CanMap (Boyko et al. 2010) , to identify size loci by scoring breeds either as ''tiny'' or ''control.'' We defined ''tiny'' breeds as those in which the average height is B10 in. (25.4 cm) at the withers. The nine breeds scored as tiny were the Brussels Griffon, Cairn Terrier, Chihuahua, Havanese, Norwich Terrier, Papillon, Pomeranian, Toy Poodle, and Yorkshire Terrier. These represent the smallest 10 % of breeds in the CanMap dataset (Supplementary Table 2 ) and are represented by 93 dogs. To avoid trait-confounding from limb-dwarfed breeds, which have very small withers heights despite their sometimes larger body sizes overall, we removed from the CanMap dataset 11 breeds that carry this trait (Parker et al. 2009 ). This left 676 dogs in 60 small, medium, and giant breeds to serve as non-tiny controls (Supplementary Table 2 ).
Comparing the nine tiny breeds to the remaining 60 breeds revealed a strong signal (p = 1.9 9 10 -70 ) on canine chromosome 3 at 43,756,620 bp ( Fig. 1 ; all genome positions are given in the CanFam2 dog genome reference assembly). Not surprisingly, the analysis also identified an association at IGF1, although this time, chromosome 15, where IGF1 lies, was not in the top tier of associations as it has been in other analyses for size (Boyko et al. 2010; Chase et al. 2002; Jones et al. 2008; Vaysse et al. 2011) .
Additional size-associated loci were also observed in this GWAS; they are the focus of other follow-up studies. For chromosome 3, the strongest associated SNP was located in a large intron in the middle of the ADAM metallopeptidase with thrombospondin type 1 motif, 17 (ADAMTS17) gene. Interestingly, a SNP in ADAMTS17 has been previously Fig. 1 Genome-wide association scan (GWAS) for tiny size as a binary trait. Dogs from nine breeds (n = 93) with breed-average withers heights of 10 in. or smaller were coded ''tiny,'' while dogs from 60 small, medium, or large breeds were coded ''control'' (n = 676). Achondrodysplastic breeds were excluded from the analysis. The x axis shows each marker's position in the genome associated with human height (Gudbjartsson et al. 2008) , although the exact function of this secreted zinc metalloprotease is still unknown.
We scanned ADAMTS17 for putative variants controlling reduced size by collecting bidirectional capillary sequence from PCR amplicons generated in ten tiny and six large dogs (Supplementary Table 1 ). Our sequencing amplicons spanned the exons and exon/intron boundaries of the gene. Among the variants found (Supplementary Table 3) , we identified three synonymous SNPs (chr3:43, 472, 198 C/T, chr3:43, 472 ,288 C/T, and chr3:43,774,819 A/G) not reported in dbSNP build 131. We also found two synonymous (rs8575121 and rs8809065) and one nonsynonymous SNP (rs8809064), which are found in dbSNP build 131. The nonsynonymous SNP is at chr3:43,778,853 and causes a V966A substitution in exon 21; this amino acid is C-terminal to one of the thrombospondin domains of the protein. It is unlikely that the V966A substitution affects ADAMTS17 function: SIFT scores it as ''tolerated,'' and PolyPhen, which uses sequence-based and structure-based predictive features, labels it ''benign,'' with a score of 0.201 and a sensitivity of 0.92 (Adzhubei et al. 2010; Kumar et al. 2009 ). Furthermore, among available GenBank records, only the dog and horse ADAMTS17 protein sequences have valine at this position. Alanine, the variant amino acid generated by the nonsynonymous SNP, is actually more common in vertebrates and is found in the ADAMTS17 protein in humans, rats, and eight other vertebrates.
Upon analysis of LD patterns at this locus, we found that CanMap markers at ADAMTS17, including the size-associated SNP, were in LD with other markers on chromosome 3. Also, LD extended for longer distances in tiny versus other sized dogs ( Supplementary Fig. 1 ). In particular, we found LD between the ADAMTS17 size-associated SNP and a set of seven contiguous SNPs that define a haplotype block spanning the insulin-like growth factor 1 receptor (IGF1R) gene, which is a highly plausible candidate for body-size variation.
Accordingly, we broadened our fine-mapping search by constructing and genotyping a custom panel of 211 SNPs in tiny and nontiny dogs. These SNPs cover a 10-Mb interval of canine chromosome 3, from 40 to 50 Mb, that is roughly centered on IGF1R, spanning 300 kb at chr3:44,650,000-44,950,000 bp. ADAMTS17 covers 330 kb at chr3:43,470,000-43,800,000 bp and is included in the finemapping scan by three SNPs within the gene plus a fourth SNP that is immediately upstream of the gene (Supplementary Table 4 ). We also discovered sequence variations in IGF1Rs exons and exon/intron boundaries by collecting bidirectional capillary sequences from PCR amplicons generated in ten tiny and six large dogs (Supplementary Table 2 ).
The fine-mapping SNPs were genotyped in 490 dogs representing 57 breeds, although the number of samples successfully genotyped at each SNP varied, partly due to the by-pool SNP-calling in the SNPlex genotyping platform (see Supplementary Table 4 for by-marker sample coverage). Of the 490 dogs, 132 were included in the GWAS and 358 were not. Because the overall number and breed number of this sample are smaller than those of the CanMap dataset used in the initial GWAS, and because the sample includes many small to medium-sized breeds, we tested for association with a quantitative size trait, i.e., we assigned a size value to every dog in a breed equal to the average withers height of an adult male in that breed (Supplementary Table 5 ). For this analysis we therefore ignored variation that occurs within each breed, instead focusing on the variation between breeds.
As shown in Fig. 2 , we identified a strong association with breed-average height at the IGF1R gene, with the peak association occurring for a SNP at chr3:44,706,389 (p = 3.6 9 10 -25 ). This is an A/G nonsynonymous SNP in the second coding exon of IGF1R that changes an arginine to histidine. None of the SNPs surrounding this one are associated, but additional association signals are obtained from SNPs immediately upstream of IGF1R and from several SNPs within the downstream third of the gene, where the majority of the gene's exons lie (Fig. 2b, c) . LD patterns over IGF1R show three independent regions of LD (Fig. 2d ). The first spans the 100 kb upstream of IGF1R. The second spans the upstream two-thirds of the transcribed portion of the gene and includes the previously mentioned nonsynonymous SNP. This region contains the SNPs in LD with the SNP in ADAMTS17 that showed the highest association with size in the GWAS. The third region covers the downstream third of the gene and most of IGF1Rs exons. The nonsynonymous SNP, unlike other SNPs within region 2, is in LD with a large fraction of the SNPs in both regions 1 and 3 (Fig. 2d) . Furthermore, it is the only SNP within region 2 that is associated with size.
We questioned whether the LD between the nonsynonymous SNP and neighboring SNPs in regions 1 and 3 was responsible for the association signals we observe for those SNPs. We therefore repeated the association analysis, but this time it was conditioned on the nonsynonymous SNP by including the SNPs genotypes in the linear model as a covariate. The majority of the association signals previously observed in regions 1 and 3 are then lost ( Supplementary Fig. 2 ), supporting the model that the size association at this locus is driven by the nonsynonymous SNP alone.
We tested the nonsynonymous SNPs association with size in a broader cross section of dogs by genotyping at this marker an additional 298 purebred dogs of variable breedaverage height; the p value in the test for association with size decreased to 1.4 9 10 -38 in the combined larger sample set of 619 samples (Fig. 2b) .
Although the nonsynonymous SNP in region 2 showed strong association with size, this was not true of the other SNPs in region 2. To investigate this, we inferred haplotypes with PHASE for the 50 SNPs of region 2, spanning chr3:44,656,749-44,852,968 (Fig. 3) . Only haplotype #2 carries the ''A'' allele for the nonsynonymous SNP at chr3:44,706,389 and it differs from the very common haplotype #1 only at the nonsynonymous SNP. This explains the lack of size association at most markers in this interval. Based on the haplotype patterns in Fig. 3 , we infer that the chr3:44,706,389 SNP ''A'' allele associated with tiny size is the derived allele, while the ''G'' allele is ancestral. Such an inference is also supported by the fact that four Golden Jackal (Canis aureus) chromosomes all carry a G at the site. This is consistent with a model in which haplotype #2 arose directly from haplotype #1 when the nonsynonymous SNPs ''A'' allele was created on a chromosome carrying haplotype #1 at IGF1Rs region 2.
Both large and tiny dog breeds carry haplotype #1, which we found in 23 breeds ( Supplementary Fig. 3 ). In contrast, the nearly identical haplotype #2 is fairly common in tiny breeds but is essentially absent in large breeds ( Supplementary Fig. 3 ). Interestingly, haplotype #2, which carries the nonsynonymous SNPs ''A'' allele, is present in the Dachshund and Poodle breeds, and in each breed it is found predominantly in the smaller-sized varieties of the breed. We assayed 13 Miniature Dachshunds for genotypes at the nonsynonymous SNP but detected only ''AA'' (Table 1) . In contrast, the larger Standard-sized Dachshunds carry all three genotypes, ''AA,'' ''AG,'' and ''GG,'' and the difference in genotype frequencies between Miniatures and Standards is significant (p \ 4.6 9 10 -4 , Fig. 2 haplotype for each of two groups of breeds: ''Tiny'' = 13 breeds in which the average adult male's height at the withers is no more than 10 in., and ''Big'' = 15 breeds with average adult male's height at the withers of at least 25 in. See also Supplementary Fig. 3 We also addressed the question of how common this allele is in dogs of intermediate size by genotyping through sequencing dogs of different breeds. In looking at individual dogs from 21 additional breeds of diverse origin with average height at the withers [10 in. but \21 in., we found that samples from 13 of the 21 breeds carried no chromosomes with the tiny-size-associated ''A'' allele. Of the eight breeds in which the ''A'' allele was detected, most were quite small (Chinese Crested, Italian Greyhound, Toy Fox Terrier) or of variable size (Jack Russell Terrier, Shetland Sheepdog). We also found the ''A'' allele at low frequency in Miniature Schnauzers and Bulldogs and at a higher frequency in Sussex Spaniels. The only breeds larger than the Bulldog in which we detected the ''A'' allele were the Standard Poodle and the Irish Water Spaniel.
The SNP at chr3:44,706,389 changes amino acid 204 from an arginine to a histidine (R204H). IGF1R is a tyrosine kinase receptor with proteolytically derived a and b subunits (Forbes 2011). Amino acid 204 is found in the cysteine-rich portion of the extracellular ligand-binding domain of the receptor's a subunit (Garrett et al. 1998) , which contains some of the contact points made with IGF1 ligand when it 5 The R204H mutation in IGF1R is predicted to destroy three hydrogen bonds within a nonsolvent accessible region of the cysteine-rich domain. a The structure determined by Garrett et al. (1998) with arginine at 204. The arginine side chain is at the center of the image. b The structure with histidine at residue 204 where putative hydrogen bonds to S153 (carbonyl), E200 (side chain), and T195 (side chain) have been lost binds (Keyhanfar et al. 2007) . The arginine at position 204 is not only completely conserved in all of the sequenced IGF1R proteins (Fig. 4) , but is one of just a few residues in this region of the polypeptide that is also completely conserved in the related molecule, insulin receptor. The high conservation of this amino acid, its location in the extracellular domain of the receptor, and the putative loss of hydrogen bonds in the R204H substitution (Fig. 5) all support the idea that this substitution affects receptor function. Furthermore, the SIFT score for the R204H substitution is ''not tolerated'' and PolyPhen scores it as ''probably damaging,'' with a sensitivity of 1.0 (Adzhubei et al. 2010; Kumar et al. 2009 ).
Discussion
The domestic dog is a rich resource for studying the genetic control of body size. Dog breeds differ greatly from one another in body size, weight, bone lengths, and height at the withers such that many breeds represent semi-isolated populations, illustrating one possible outcome from intense selection on size. The population structure of purebred dogs is well suited to the difficult task of unraveling complex trait genetics (Karlsson et al. 2007 ). For 99 % of the history of the dog species, from *15,000 to 100 years before the present, there was potential for gene flow between populations so that alleles under selection could move through subpopulations. In the late nineteenth century the newly formed kennel clubs initiated policies of strict reproductive isolation for each pure breed of dog. With few exceptions these policies continue to this day, so that each breed carries the particular set of alleles provided to it by its founding members a century ago. Under such conditions, the issues of founder effect, chronically small population sizes, genetic drift, and in some cases intense selection lead us to hypothesize that while there may be many size-controlling loci in the dog genome, perhaps any particular breed is likely fixed for a single allele at several such loci. This reduction in locus heterogeneity greatly simplifies mapping by limiting the number of segregating loci that must be simultaneously identified (Karlsson et al. 2007; Ostrander and Wayne 2005) . In this study we aimed to understand the genetic control of tiny size in the domestic dog. We first investigated the ADAMTS17 gene because it is directly within the topranked size-associated locus identified in our GWAS. However, our mutation scanning by capillary sequencing detected no obvious candidates likely to be causal for size. The only nonsynonymous SNP identified in the region represents a fairly conservative amino change from valine to alanine, and most vertebrates sequenced to date contain an alanine at this position. Furthermore, there are reports that have identified a severe truncating mutation in this gene as the cause of primary lens luxation in the dog (Farias et al. 2010) , and as noted by the authors, none of their data or previous reports indicate a difference in size between affected and unaffected dogs. This mutation has been found in 14 of 30 breeds tested in a recent study (Gould et al. 2011) , and although most of the breeds with the mutation are small, the more striking relationship common to most breeds with the mutation is that they are terriers or from breeds with putative terrier ancestry (Gould et al. 2011) . Therefore, while our mapping does not formally exclude ADAMTS17 and, as proposed by Farias et al. (2010) , a careful analysis of body size in breeds with the primary lens luxation mutation would be worthwhile, we consider the variation in ADAMTS17 an unlikely candidate for contributing to anything but perhaps subtle differences in dog body size.
The GWAS size-associated SNP within ADAMTS17 is in LD with several SNPs in a block spanning the IGF1R gene 900 kb away; LD often extends a megabase pair or more in purebred dogs (Lindblad-Toh et al. 2005; Sutter et al. 2004 ). Fine-mapping identified a nonsynonymous SNP within the second protein-coding exon of IGF1R that is associated with tiny size and is predicted to cause an amino acid change from arginine to histidine at residue 204. There are several lines of evidence supporting the idea that the alleles of this SNP functionally contribute to body size differences. First, inspection of the IGF1R protein structure (Garrett et al. 1998) suggests that the substitution to histidine may prevent formation of several hydrogen bonds that form between the arginine side group and neighboring atoms. Amino acid R204 is in a nonsolvent accessible region of the protein and, as would be predicted, there are potential acceptors in close proximity to form hydrogen bonds with the atoms of the side chain of arginine. The backbone carbonyl of S153, the carbonyl group of E200, and the side chain of T195 are all within 3.48 Å of atoms in R204s side chain. All of these residues are conserved in the predicted IGF1R protein in the dog. Replacement of the arginine at position 204 with a histidine residue eliminates the possibility of several of these hydrogen bonds and may also generate a steric clash with T195. The R204 amino acid is part of a loop found at the base of the extracellular domain, and the hydrogen bonds would be predicted to promote interaction of the loop with the rest of the domain. The arginine found at this position is highly conserved as it is invariant not only in IGF1R but also in the related insulin receptor proteins from mammals, birds, frogs, and fish.
In addition, we find the nonsynonymous SNP in a diverse set of tiny dog breeds, but almost no large breeds carry it. Furthermore, the trend within both Poodle and Dachshund size varieties is toward an increasing ''A'' allele frequency as size decreases (from the Standard variety down to the Miniature and Toy in the Poodle and from Standard to Miniature in the Dachshund). These results are also consistent with the identification of a signature of selection that spans the IGF1R gene (Akey et al. 2010; Vaysse et al. 2011) . We hypothesize, therefore, that the IGF1R nonsynonymous SNP at chr3:44,706,389 is a causal mutation for tiny size in dogs. Future functional studies will be needed to determine the precise nature of this variant.
While we cannot exclude more complex scenarios, our results are consistent with the model that this SNP is the only causal mutation contributing to size variation at this locus. We did observe other association signals at IGF1R, both upstream of transcription and over the downstream coding exons, but these signals appear to be spuriously derived from the nonsynonymous SNP via LD. Mutations in the IGF1R gene in mice and humans that eliminate or decrease receptor levels or activity have been shown to affect body size. As noted earlier, homozygous knock outs of the IGF1R gene in mice is lethal perinatally, and pups are born at only 45 % of normal body mass (Liu et al. 1993) . Mice heterozygous for gene knockouts (Bokov et al. 2011; Liu et al. 1993) or tissuespecific knockouts (Kappeler et al. 2008; Romero et al. 2010 ) also have reduced body size or mass. Several human families have been described in which heterozygous mutations in IGF1R have been linked to intrauterine and postnatal growth defects; some of these mutations have been shown to decrease IGF1 signaling through a variety of mechanisms (reviewed by Kawashima et al. 2012) .
The results reported here, together with our previous findings, underscore the critical importance of the IGF1 pathway in controlling dog size. The IGF1 pathway affects a number of different tissues during development and postnatally, and complex interrelationships exist between this pathway and the growth hormone pathway (Netchine et al. 2011 ). The IGF1 small-size haplotype is correlated with a significant reduction in circulating levels of IGF1 hormone (Sutter et al. 2007) . In this study we found that many of the tiniest dogs also carry an R204H mutation in their IGF1 receptor. Thus, these tiny dogs have reduced levels of IGF1 and, we hypothesize, may also have a reduced capacity to bind IGF1 at its receptor or transduce signals that should result from binding. We found many dogs that are homozygous for the R204H mutation, suggesting that the mutant IGF1R does have at least some function; R204H homozygous dogs do not die at birth as do mice homozygous for an IGF1R knockout (Liu et al. 1993) .
IGF1 and IGF2 hormones promote cell growth, survival, and differentiation by binding the IGF1 receptor, which is a transmembrane receptor tyrosine kinase with a structure very similar to the insulin receptor: it contains two a and two b subunits (Forbes 2011). IGF1Rs extracellular a subunit binds ligands via contacts at several domains and there is evidence that the cysteine-rich domain is involved in the binding of IGF1 but not IGF2 (Forbes 2011; Keyhanfar et al. 2007 ). The dog R204H mutation is located in the cysteine-rich domain of the extracellular a subunit so it is possible that the mutation may affect IGF1 binding differently than IGF2 binding. A human mutation in the IGF1-C domain causes growth deficiency, just as other IGF1 mutations do, but it does so without also causing the severe development delay and deafness that result from other mutations in human IGF1 (Netchine et al. 2009 (Netchine et al. , 2011 . The IGF1-C domain makes contact with the IGF1R cysteine-rich domain; perhaps the dog R204H mutation in the cysteine-rich domain is able to confer a desirable small size without negative effects on hearing or developmental delay.
The IGF1R nonsynonymous SNP's ''A'' allele is present in many, but not all, of the tiny breeds we studied. It may be that the pattern we previously found at the IGF1 gene, in which essentially all small dogs are fixed for a single allele, is the exception rather than the rule for many loci contributing to dog size. The IGF1 allele has a large effect on size, while the IGF1R mutation we report here appears to have a more modest effect: it contributes to very small size but dogs can be tiny without carrying it. Our data therefore support the idea that there exist different combinations of alleles that can produce tiny dog size. All tiny breeds are intensely selected for their diminutive sizes, but it seems they can arrive there by different genetic means. It appears that all such combinations of genetic factors do require the IGF1 allele, but small-size alleles at other loci, like IGF1R, may or may not be needed in a particular tiny breed.
Such a scenario is consistent with the known history of breed creation via tight population bottlenecks. Many alleles are likely to be lost in chronically small and highly inbred populations such as purebred dogs, and if a tiny-sized breed should ever become fixed for a large-size allele at a locus (via genetic drift despite selection for small size, for example), there are no means to ever recover the small-size allele except by new mutation. At the point when additional size loci have been identified in dogs, it will be interesting to learn whether any tiny breeds carry the small-size-associated alleles at every size locus. If none do, it will suggest that either the vagaries of drift and breed isolation prevented such a fortunate combination or that such a combination is not biologically compatible with life or health.
